Omega Therapeutics

Provider of platform for human genome study for precision medicine

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups93 employees language omegatherapeutics.com

Registered entities

Investor mix

11 investors on record; lead investors include Invus, Logos, Point72, Cowen.

Investor typeCountShare
Venture capital327%
Private equity218%
Bank & private debt327%
Other / undisclosed327%
Coming soon